BACKGROUND: Sensitivity to reward has been implicated as a predisposing factor for behaviors related to drug abuse as well as overeating. However, the underlying mechanisms contributing to reward sensitivity are unknown. We hypothesized that a dysregulation in dopamine signaling might be an underlying cause of heightened reward sensitivity whereby rewarding stimuli could act to normalize the system. METHODS: We used a genetic mouse model of increased reward sensitivity, the Delta FosB-overexpressing mouse, to examine reward pathway changes in response to a palatable high-fat diet. Markers of reward signaling in these mice were examined both basally and following 6 weeks of palatable diet exposure. Mice were examined in a behavioral test following high-fat diet withdrawal to assess the vulnerability of this model to removal of rewarding stimuli. RESULTS: Our results demonstrate altered reward pathway activation along the nucleus accumbens-hypothalamic-ventral tegmental area circuitry resulting from overexpression of Delta FosB in the nucleus accumbens and striatal regions. Levels of phosphorylated cyclic adenosine monophosphate (cAMP) response element binding protein (pCREB), brain-derived neurotrophic factor (BDNF), and dopamine and cyclic adenosine monophosphate regulated phosphoprotein with a molecular mass of 32 kDa (DARPP-32) in the nucleus accumbens were reduced in Delta FosB mice, suggestive of reduced dopamine signaling. Six weeks of high-fat diet exposure completely ameliorated these differences, revealing the potent rewarding capacity of a palatable diet. Delta FosB mice also showed a significant increase in locomotor activity and anxiety-related responses 24 hours following high-fat withdrawal. CONCLUSIONS: These results establish an underlying sensitivity to changes in reward related to dysregulation of Delta FosB and dopamine signaling that can be normalized with palatable diets and may be a predisposing phenotype in some forms of obesity.
BACKGROUND: Sensitivity to reward has been implicated as a predisposing factor for behaviors related to drug abuse as well as overeating. However, the underlying mechanisms contributing to reward sensitivity are unknown. We hypothesized that a dysregulation in dopamine signaling might be an underlying cause of heightened reward sensitivity whereby rewarding stimuli could act to normalize the system. METHODS: We used a genetic mouse model of increased reward sensitivity, the Delta FosB-overexpressing mouse, to examine reward pathway changes in response to a palatable high-fat diet. Markers of reward signaling in these mice were examined both basally and following 6 weeks of palatable diet exposure. Mice were examined in a behavioral test following high-fat diet withdrawal to assess the vulnerability of this model to removal of rewarding stimuli. RESULTS: Our results demonstrate altered reward pathway activation along the nucleus accumbens-hypothalamic-ventral tegmental area circuitry resulting from overexpression of Delta FosB in the nucleus accumbens and striatal regions. Levels of phosphorylated cyclic adenosine monophosphate (cAMP) response element binding protein (pCREB), brain-derived neurotrophic factor (BDNF), and dopamine and cyclic adenosine monophosphate regulated phosphoprotein with a molecular mass of 32 kDa (DARPP-32) in the nucleus accumbens were reduced in Delta FosBmice, suggestive of reduced dopamine signaling. Six weeks of high-fat diet exposure completely ameliorated these differences, revealing the potent rewarding capacity of a palatable diet. Delta FosBmice also showed a significant increase in locomotor activity and anxiety-related responses 24 hours following high-fat withdrawal. CONCLUSIONS: These results establish an underlying sensitivity to changes in reward related to dysregulation of Delta FosB and dopamine signaling that can be normalized with palatable diets and may be a predisposing phenotype in some forms of obesity.
Authors: Eun Sung Park; Seong Joon Yi; Jin Sang Kim; Heungshik S Lee; In Se Lee; Je Kyung Seong; Hee Kyung Jin; Yeo Sung Yoon Journal: J Vet Sci Date: 2004-12 Impact factor: 1.672
Authors: M B Kelz; J Chen; W A Carlezon; K Whisler; L Gilden; A M Beckmann; C Steffen; Y J Zhang; L Marotti; D W Self; T Tkatch; G Baranauskas; D J Surmeier; R L Neve; R S Duman; M R Picciotto; E J Nestler Journal: Nature Date: 1999-09-16 Impact factor: 49.962
Authors: Abraham A Palmer; Miguel Verbitsky; Rathi Suresh; Helen M Kamens; Cheryl L Reed; Na Li; Sue Burkhart-Kasch; Carrie S McKinnon; John K Belknap; T Conrad Gilliam; Tamara J Phillips Journal: Mamm Genome Date: 2005-05 Impact factor: 2.957
Authors: Brian A Baldo; Lisa Gual-Bonilla; Karuna Sijapati; Roger A Daniel; Charles F Landry; Ann E Kelley Journal: Eur J Neurosci Date: 2004-01 Impact factor: 3.386
Authors: Theodore A Slotkin; T Leon Lassiter; Ian T Ryde; Nicola Wrench; Edward D Levin; Frederic J Seidler Journal: Environ Health Perspect Date: 2009-02-03 Impact factor: 9.031
Authors: Christina H Liu; Jia Q Ren; Jinsheng Yang; Charng-ming Liu; Joseph B Mandeville; Bruce R Rosen; Pradeep G Bhide; Yuchio Yanagawa; Philip K Liu Journal: J Neurosci Date: 2009-08-26 Impact factor: 6.167
Authors: Theodore A Slotkin; Nicola Wrench; Ian T Ryde; T Leon Lassiter; Edward D Levin; Frederic J Seidler Journal: Neurotoxicol Teratol Date: 2009-07-16 Impact factor: 3.763
Authors: Jenna A McHenry; Christopher L Robison; Genevieve A Bell; Vincent V Vialou; Carlos A Bolaños-Guzmán; Eric J Nestler; Elaine M Hull Journal: Behav Neurosci Date: 2016-10 Impact factor: 1.912